1
|
Giles ME, Thomson C, Eyley SC, Cole AJ, Goodwin CJ, Hurved PA, Morlin AJG, Tornos J, Atkinson S, Just C, Dean JC, Singleton JT, Longton AJ, Woodland I, Teasdale A, Gregertsen B, Else H, Athwal MS, Tatterton S, Knott JM, Thompson N, Smith SJ. Development of a Manufacturing Process for Sibenadet Hydrochloride, the Active Ingredient of Viozan. Org Process Res Dev 2004. [DOI: 10.1021/op049953y] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Melvyn E. Giles
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Colin Thomson
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Stephen C. Eyley
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Andrea J. Cole
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Christopher J. Goodwin
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Paul A. Hurved
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Andrew J. G. Morlin
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - James Tornos
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Stéphanie Atkinson
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Cecelia Just
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Janet C. Dean
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - John T. Singleton
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Andrew J. Longton
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Ian Woodland
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Andrew Teasdale
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Björn Gregertsen
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Howard Else
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Mandip S. Athwal
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Stephen Tatterton
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Jason M. Knott
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Nicola Thompson
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| | - Stephen J. Smith
- AstraZeneca R & D Charnwood, Process R & D, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom
| |
Collapse
|
2
|
Maruyama T, Kuwabe SI, Kawanaka Y, Shiraishi T, Shinagawa Y, Sakata K, Seki A, Kishida Y, Yoshida H, Maruyama T, Ohuchida S, Nakai H, Hashimoto S, Kawamura M, Kondo K, Toda M. Design and synthesis of a selective EP4-receptor agonist. Part 4: practical synthesis and biological evaluation of a novel highly selective EP4-receptor agonist. Bioorg Med Chem 2002; 10:2103-10. [PMID: 11983506 DOI: 10.1016/s0968-0896(02)00085-8] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
A practical method of synthesizing a highly selective EP4-receptor agonist 1 using Corey lactone 2 as a key intermediate was developed. Selective methanesulfonylation of the primary alcohol of the diol 8 under the newly devised conditions followed by the protection of the remaining secondary alcohol are key reactions in this new method. Further biological evaluation of 1a-b is also reported.
Collapse
Affiliation(s)
- Toru Maruyama
- Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|